| (Asp76)-pTH (39-84) (human) |
C211H356N66O73 |
4985.55 |
79804-72-1 |
H-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| (Tyr43)-pTH (43-68) (human) |
C126H208N42O43 |
2999.29 |
92952-95-9 |
H-Tyr-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH |
| pTH (44-68) (human) |
C117H199N41O41 |
2836.12 |
64421-69-8 |
H-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH |
| Biotinyl-pTH (44-68) (human) |
C127H213N43O43S |
3062.42 |
198341-96-7 |
Biotinyl-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH |
| (Tyr52)-pTH (52-84) (human) |
C158H262N44O56 |
3674.08 |
|
H-Tyr-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| (Tyr52,Asp76)-pTH (52-84) (human) |
C158H261N43O57 |
3675.07 |
84069-01-2 |
H-Tyr-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| pTH (53-84) (human) |
C149H253N43O54 |
3510.91 |
|
H-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| pTH (64-84) (human) |
C94H163N27O35 |
2231.49 |
129449-07-6 |
H-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| Biotinyl-pTH (64-84) (human) |
C104H177N29O37S |
2457.79 |
|
Biotinyl-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| pTH (70-84) (human) |
C67H118N20O24 |
1587.79 |
|
H-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| pTH (73-84) (human) |
C54H96N16O19 |
1273.45 |
|
H-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
| M65, PAC1 Receptor Antagonist M65 |
C199H314N62O60S5 |
4695.39 |
|
H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Glu-Phe-Lys-Ala-NH2 (Disulfide bonds between Cys¹ and Cys⁵/Cys¹⁴ and Cys³²) |
| Maxadilan |
C291H466N86O94S6 |
6865.82 |
135374-80-0 |
H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Leu-Gln-Thr-Ser-Val-Gln-Thr-Thr-Ala-Thr-Phe-Thr-Ser-Met-Asp-Thr-Ser-Gln-Leu-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-NH2 (Disulfide bonds between Cys¹ and Cys⁵/Cys¹⁴ and Cys⁵¹) |
| H-Phe-Gly-Phe-Gly-OH |
C22H26N4O5 |
426.47 |
59005-83-3 |
H-Phe-Gly-Phe-Gly-OH |
| H-D-Tyr-Val-NH2 |
C14H21N3O3 |
279.34 |
87237-39-6 |
H-D-Tyr-Val-NH2 |
| H-D-Tyr-Val-Gly-OH |
C16H23N3O5 |
337.38 |
86030-52-6 |
H-D-Tyr-Val-Gly-OH |
| Ac-Ala-Ala-Ser(PO3H2)-Pro-Arg-pNA |
C28H43N10O12P |
742.68 |
202739-37-5 |
Ac-Ala-Ala-Ser(PO3H2)-Pro-Arg-pNA |
| Suc-Ala-Ala-Pro-Phe-AMC |
C34H39N5O9 |
661.71 |
88467-45-2 |
Suc-Ala-Ala-Pro-Phe-AMC |
| Suc-Ala-Ala-Pro-Phe-2,4-difluoroanilide |
C30H35F2N5O7 |
615.63 |
381164-12-1 |
Suc-Ala-Ala-Pro-Phe-2,4-difluoroanilide |
| Suc-Ala-Ala-Pro-Phe-pNA |
C30H36N6O9 |
624.65 |
70967-97-4 |
Suc-Ala-Ala-Pro-Phe-pNA |
ght:4��p'8��h��height=61 class=xl65 style='height:45.75pt'>pTH (18-48) (human) C156H251N47O43S 3505.07 153238-99-4 H-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-OH (Tyr27)-pTH (27-48) (human) C104H159N29O31 2311.58 90686-51-4 H-Tyr-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-OH pTH (28-48) (human) C95H150N28O29 2148.41 83286-22-0 H-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-OH pTH (29-32) (human) C20H31N7O8 497.51 157879-49-8 H-Gln-Asp-Val-His-OH
